This inventor holds 1 USPTO granted patent. Top assignees: The General Hospital Corporation, University of Massachusetts. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2011
Title: Valeriy Metelev: Innovator in Nucleoside Analog Research
Introduction
Valeriy Metelev is a prominent inventor based in Moscow, Russia. He has made significant contributions to the field of nucleoside analogs, particularly through his innovative patent work. His research has implications in therapeutic, diagnostic, and research applications.
Latest Patents
Valeriy Metelev holds a patent for phosphoramidite nucleoside analogs. This patent describes phosphoramidite nucleoside analog monomers, their precursors, and oligonucleotides that include one or more of these monomers. The monomers are designed for use in the automated synthesis of oligonucleotide derivatives. They allow for the incorporation of various reporter groups, organic molecules, bio-molecules, small molecules, or other chemical groups at the internucleoside phosphotriesters. The oligonucleotides that include these monomers have numerous applications in therapeutic, diagnostic, and research fields.
Career Highlights
Throughout his career, Valeriy Metelev has worked with notable institutions, including The General Hospital Corporation and the University of Massachusetts. His work has been instrumental in advancing the understanding and application of nucleoside analogs in various scientific domains.
Collaborations
Valeriy has collaborated with esteemed colleagues such as Paul C. Zamecnik and David R. Tabatadze. These collaborations have further enriched his research and contributed to the scientific community's knowledge in the field.
Conclusion
Valeriy Metelev's contributions to the field of nucleoside analogs highlight his innovative spirit and dedication to advancing scientific research. His work continues to influence therapeutic and diagnostic applications, showcasing the importance of his inventions in modern science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile